Company intelligence / Profile preview

IPS Pharma

West Molesey, Surrey, United Kingdomips-pharma.com ↗

Ownership: Private
Employees: ~54
Development stage: Commercial

Overview

IPS Pharma manufactures and supplies unlicensed medicines ("specials") to meet unmet clinical needs, supports global clinical trials with investigational medicinal products, comparators, and offers regulatory/packaging/compounding services. They have collaborated on importation of cannabinoid-based IMPs for late-stage studies. No proprietary drug development pipeline.

Modalities: Small moleculeBiologic
Industry: Contract Manufacturing Organization

Partnerships

Columbia Care Inc. – collaboration to import BeneCeed CBD tablets as an investigational medicinal product for UK clinical study

Beyond the preview

Go deeper on IPS Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IPS Pharma.

Explore the full profile